<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319712463421</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319712463421</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Response Letter</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Does Serum Uric Acid Level Affect Coronary Collaterals in Patients With Acute Coronary Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Duran</surname>
<given-names>Mustafa</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712463421">1</xref>
<xref ref-type="corresp" rid="corresp1-0003319712463421"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Murat</surname>
<given-names>Sani N.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319712463421">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ornek</surname>
<given-names>Ender</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319712463421">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0003319712463421">
<label>1</label>Department of Cardiology, Kayseri Education and Research Hospital, Kayseri, Turkey</aff>
<aff id="aff2-0003319712463421">
<label>2</label>Department of Cardiology, Ankara Education and Research Hospital, Ankara, Turkey</aff>
<author-notes>
<corresp id="corresp1-0003319712463421">Mustafa Duran, Department of Cardiology, Kayseri Education and Research Hospital, Kayseri, Turkey. Email: <email>mduran2@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>64</volume>
<issue>4</issue>
<fpage>325</fpage>
<lpage>326</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<kwd-group>
<kwd>serum uric acid</kwd>
<kwd>coronary collateral vessel</kwd>
<kwd>acute coronary syndrome</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>We reported a negative effect of serum uric acid (SUA) level on the development of coronary collateral vessel (CCV) in patients with acute coronary syndrome (ACS).<sup>
<xref ref-type="bibr" rid="bibr1-0003319712463421">1</xref>
</sup> We read with interest the letter to the editor by Hsu et al<sup>
<xref ref-type="bibr" rid="bibr2-0003319712463421">2</xref>
</sup> about an association between SUA and CCV.</p>
<p>Hsu et al<sup>
<xref ref-type="bibr" rid="bibr2-0003319712463421">2</xref>
</sup> reviewed their coronary angiographic data to look for similar result in a Chinese population. They reported that SUA level did not have a significant association with the presence and development of CCV.</p>
<p>Differing from the study by Hsu et al,<sup>
<xref ref-type="bibr" rid="bibr2-0003319712463421">2</xref>
</sup> we excluded patients with a history of diabetes mellitus, hypertension, renal disease, past coronary intervention or coronary artery bypass grafting, inflammatory rheumatic disease, and chronic obstructive pulmonary disease. All these parameters may affect the development of collaterals and/or levels of SUA.<sup>
<xref ref-type="bibr" rid="bibr3-0003319712463421">3</xref>
<xref ref-type="bibr" rid="bibr4-0003319712463421"/>–<xref ref-type="bibr" rid="bibr5-0003319712463421">5</xref>
</sup> Hsu et al<sup>
<xref ref-type="bibr" rid="bibr2-0003319712463421">2</xref>
</sup> did not report exclusion criteria clearly in their study, and they included diabetic and hypertensive patients. Although the number of diabetic and hypertensive patients was similar in both groups, it is very difficult to predict the exact effects of hypertension and diabetes on the development of collaterals. Because abnormal values of liver function tests and triglycerides can affect SUA levels and vascular risk, we excluded patients with abnormal liver function tests and triglycerides.<sup>
<xref ref-type="bibr" rid="bibr3-0003319712463421">3</xref>,<xref ref-type="bibr" rid="bibr6-0003319712463421">6</xref>
</sup>
</p>
<p>Endothelial dysfunction and decreased nitric oxide (NO) production were suggested as an underlying mechanism for the absence of CCVs,<sup>
<xref ref-type="bibr" rid="bibr7-0003319712463421">7</xref>
</sup> and SUA contributes directly to the endothelial dysfunction by inducing antiproliferative effects and impairing NO production.<sup>
<xref ref-type="bibr" rid="bibr8-0003319712463421">8</xref>
</sup> The SUA is associated with high oxidative stress, formation of free radicals, and facilitates lipid peroxidation, which are important factors in both angiogenesis and atherogenesis.<sup>
<xref ref-type="bibr" rid="bibr9-0003319712463421">9</xref>,<xref ref-type="bibr" rid="bibr10-0003319712463421">10</xref>
</sup> Because of the negative effects of SUA on angiogenesis and atherogenesis, we hypothesized that in nondiabetic, nonhypertensive patients with ACS, high levels of SUA affect the CCV development negatively in our study. Hyperuricemia may also cause microvascular damage in the renal vascular bed and exacerbate vascular disease.<sup>
<xref ref-type="bibr" rid="bibr11-0003319712463421">11</xref>
</sup> Similarly, as our results showed, high SUA levels may cause damage in microvascular coronary vessels and may result in poorly developed CCV or absence of collaterals.</p>
<p>We know that myocardial ischemia is one of the important determinants of coronary collateral development.<sup>
<xref ref-type="bibr" rid="bibr12-0003319712463421">12</xref>
</sup> Hsu et al<sup>
<xref ref-type="bibr" rid="bibr2-0003319712463421">2</xref>
</sup> reported that the patients with poor CCV had fewer diseased vessels. In our study, there was no association between the burden of coronary artery disease and the development of collaterals. The results might have been different (at least in multivariate analysis) if we had evaluated the effect of burden of coronary artery disease.</p>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0003319712463421">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0003319712463421">
<label>Funding</label>
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319712463421">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duran</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ornek</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Murat</surname>
<given-names>SN</given-names>
</name>
<etal/>
</person-group>. <article-title>High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome</article-title>. <source>Angiology</source>. <year>2012</year>;<volume>63</volume>(<issue>6</issue>):<fpage>472</fpage>–<lpage>475</lpage>.</citation>
</ref>
<ref id="bibr2-0003319712463421">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>TH.</given-names>
</name>
</person-group> <article-title>Association between coronary collaterals and serum uric acid level in Chinese population with acute coronary syndrome</article-title>. <source>Angiology</source>. <year>2013</year>;<volume>64</volume>(<issue>4</issue>):<fpage>323</fpage>–<lpage>324</lpage>.</citation>
</ref>
<ref id="bibr3-0003319712463421">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ozyurt</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ceyhan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Koc</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Celik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Burucu</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>The relationship between high-density lipoprotein cholesterol and coronary collateral circulation in patients with coronary artery disease</article-title>. <source>J Investig Med</source>. <year>2012</year>;<volume>60</volume>(<issue>5</issue>):<fpage>808</fpage>–<lpage>812</lpage>.</citation>
</ref>
<ref id="bibr4-0003319712463421">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Juo</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>HM</given-names>
</name>
<etal/>
</person-group>. <article-title>Predictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease. [published online August 30, 2012]</article-title>. <source>BMC Nephrol</source>. <year>2012</year>;<volume>13</volume>(<issue>1</issue>):<fpage>98</fpage>.</citation>
</ref>
<ref id="bibr5-0003319712463421">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seiler</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>The human coronary collateral circulation</article-title>. <source>Eur J Clin Invest</source>. <year>2010</year>;<volume>40</volume>(<issue>5</issue>):<fpage>465</fpage>–<lpage>476</lpage>.</citation>
</ref>
<ref id="bibr6-0003319712463421">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katsiki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Athyros</surname>
<given-names>VG</given-names>
</name>
<name>
<surname>Karagiannis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mikhailidis</surname>
<given-names>DP</given-names>
</name>
</person-group>. <article-title>Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): a relationship with implications for vascular risk?</article-title> <source>Curr Vasc Pharmacol</source>. <year>2011</year>;<volume>9</volume>(<issue>6</issue>):<fpage>698</fpage>–<lpage>705</lpage>.</citation>
</ref>
<ref id="bibr7-0003319712463421">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsunaga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Warltier</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Weihrauch</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Moniz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tessmer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chilian</surname>
<given-names>WM</given-names>
</name>
</person-group>. <article-title>Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide</article-title>. <source>Circulation</source>. <year>2000</year>;<volume>102</volume>(<issue>25</issue>):<fpage>3098</fpage>–<lpage>3103</lpage>.</citation>
</ref>
<ref id="bibr8-0003319712463421">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanellis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>DH</given-names>
</name>
</person-group>. <article-title>Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease</article-title>. <source>Semin Nephrol</source>. <year>2005</year>;<volume>25</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr9-0003319712463421">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasquez-Vivar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Junqueira</surname>
<given-names>VB</given-names>
</name>
<name>
<surname>Augusto</surname>
<given-names>O.</given-names>
</name>
</person-group> <article-title>Peroxynitrite-mediated formation of free radicals in human plasma: EPR detection of ascorbyl, albumin-thiyl and uric acid derived free radicals</article-title>. <source>Biochem J</source>. <year>1996</year>;<volume>314</volume>(<issue>pt 3</issue>):<fpage>869</fpage>–<lpage>876</lpage>.</citation>
</ref>
<ref id="bibr10-0003319712463421">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anker</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Leyva</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Poole-Wilson</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Kox</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Coats</surname>
<given-names>AJ</given-names>
</name>
</person-group>. <article-title>Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure</article-title>. <source>Heart</source>. <year>1997</year>;<volume>78</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr11-0003319712463421">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanbay</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sánchez-Losada</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin</article-title>. <source>Nephrol Dial Transplant</source>. <year>2011</year>;<volume>26</volume>(<issue>2</issue>):<fpage>430</fpage>–<lpage>437</lpage>.</citation>
</ref>
<ref id="bibr12-0003319712463421">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koerselman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van der Graaf</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>de Jaegere</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Grobbee</surname>
<given-names>DE</given-names>
</name>
</person-group>. <article-title>Coronary collaterals: an important and underexposed aspect of coronary artery disease</article-title>. <source>Circulation</source>. <year>2003</year>;<volume>107</volume>(<issue>19</issue>):<fpage>2507</fpage>–<lpage>2511</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>